lifestyle.longislandreport.org
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Alvotech
Alvotech Files Annual Report with the SEC
March 30, 2026
Alvotech Q4 2025 and Full Year 2025 Financial Results
March 18, 2026
Alvotech to Report Fourth Quarter and Full Year 2025 Financial Results
March 4, 2026
Alvotech Announces Positive Top-Line Results from Pivotal Pharmacokinetic Study for Proposed Biosimilar to Entyvio®
February 11, 2026
Alvotech enters supply and commercialization agreements for Canada and Australia & New Zealand covering multiple biosimilar candidates
February 2, 2026
Alvotech Secures Settlement Agreement in Global Markets for its Biosimilar to Eylea® 2mg
January 29, 2026